Join Associate Professor Shalini Arunogiri for a webinar exploring emerging treatments in the alcohol and other drugs (AOD) sector, with a focus on psychedelic-assisted therapies. Dr. Arunogiri is a clinical psychiatrist specialising in addiction and the Deputy Clinical Director at Turning Point, a national centre for addiction treatment, research, and education. She is also an NHMRC Emerging Leadership Fellow at Monash University, where she leads research into innovative approaches to treating substance use and co-occurring mental health disorders. With extensive contributions to national policy, clinical training, and service development, Dr. Arunogiri is a recognised leader in the AOD field and currently serves on the board of the Australasian Professional Society on Alcohol and other Drugs (APSAD). Key learning outcomes: By the end of this webinar, attendees will be able to: – Understand the current evidence base for the use of MDMA and psilocybin in addiction and related mental health problems – Understand key evidence gaps in existing evidence in psychedelic assisted therapies – Identify and critically appraise challenges with implementation of psychedelic assisted therapies in Australia